GlassScriptPhysician profile
David T Netscher
NPI 1346272390
$1,248.48
in general payments reported to CMS, 2019-2025
9 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $112 · 2021: $76.21 · 2022: $20.10 · 2023: $412 · 2024: $166 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $496.24 | 2021-2025 | Osteomed, Acumed |
| Stryker Corporation | $276.42 | 2020-2025 | Variax, Axsos, Augment Injectable |
| Integra Lifesciences Corporation | $185.44 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $90.91 | 2019-2022 | |
| Axogen | $66.86 | 2019 | |
| Ossio INC | $43.88 | 2019 | |
| Mentor Worldwide LLC | $36.85 | 2021 | |
| Depuy Synthes Sales INC. | $30.82 | 2025 | Quickanchor Orthocord, Vapr, Truespan Orthocord |
| Kerecis Limited | $21.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Netscher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.